An Efficacy Evaluation of Bawei Qidan Capsule Combined with Epalrestat in the Treatment of Type 2 Diabetic Peripheral Neuropathy

An Efficacy Evaluation of Bawei Qidan Capsule Combined with Epalrestat in the Treatment of Type 2 Diabetic Peripheral Neuropathy

TIAN Bin, ZHOU Li, JI Yuanhong, ZHANG Hongyan

PDF(953 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(953 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (9) : 1532-1535. DOI: 10.11748/bjmy.issn.1006-1703.2022.09.021

Clinical Investigation

An Efficacy Evaluation of Bawei Qidan Capsule Combined with Epalrestat in the Treatment of Type 2 Diabetic Peripheral Neuropathy

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(9): 1532-1535 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.09.021

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(953 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉